New program aims to boost HIV prevention in ugandan teens with education, peer support, and savings accounts

NCT ID NCT07002866

Recruiting now Prevention Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study enrolls 600 adolescent girls and young women (ages 15-24) at high risk of HIV in Uganda. Participants are randomly assigned to one of three groups: HIV risk reduction sessions alone, sessions plus peer support, or sessions plus peer support and a matched savings account. The goal is to see which combination best helps them start and consistently take PrEP, a daily pill that prevents HIV. The program runs for 20 months, with follow-up over three years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (HIV risk reduction sessions, peer support, and matched savings accounts)
What this could lead to: If successful, this could provide a practical, community-based model to significantly reduce new HIV infections among young women in high-risk areas.
What could go wrong: This is a behavioral study, not a drug trial, so results depend on participation and follow-up. It may not work in other settings or for all individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION

Contacts and locations

Locations

International Center for Child Health and Development (ICHAD)
RECRUITING

Masaka, Uganda
Washington University in St. Louis
ACTIVE_NOT_RECRUITING

St Louis, Missouri, 63130, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.